South Korea
-
Korea Electric Power Corp (Kepco) made a remarkable return to the debt market on Monday, selling a $500m green bond as its first public dollar deal in 15 years. -
The Republic of Korea issued a dual-tranche dollar bond on Wednesday, with the shorter dated portion carrying a green and sustainability label.
-
South Korean oil refiner GS Caltex Corp raised $300m from a senior bond on Wednesday.
-
KEB Hana Bank turned its attentions to Taiwan on Tuesday, raising $400m in a Formosa bond sale.
-
Biopharmaceuticals company Mabpharm launched bookbuilding for its up to HK$1.53bn ($195m) flotation, while Hansoh Pharmaceutical Group set pre-marketing in motion for its Hong Kong listing.
-
SG moves London banker to run Asia syndicate team — Citi loses head of India DCM — ANZ loans banker to relocate to Singapore — MSCI names Korea client head.
-
JP Morgan’s private equity arm has bagged W390.7bn ($327.5m) after selling a chunk of shares in South Korean firm Celltrion Healthcare, according to a source close to the deal.
-
South Korean company SK Biopharmaceuticals is planning to launch an IPO by the end of 2019 and could net proceeds of up to around W1tr ($838.5m), according to a source close to the deal.
-
MSCI has poached Tay Kim from Franklin Templeton Investment Trust Management to lead client coverage for the firm in South Korea.
-
Korea Railroad Corp turned west on Monday, marketing a six year bond to Swiss investors.
-
Woori Bank turned to Taiwan this week for its latest dollar transaction, raising $450m from the first sustainability-labelled Formosa deal.
-
With South Korea and the Philippines heading to euros for new bond transactions, more issuers from Asia should take courage and consider funding in the needlessly neglected currency.
